# A Study of Single Ascending Doses of STAR-101 in Healthy Participants

> **NCT04081597** · PHASE1 · WITHDRAWN · sponsor: **Acanthas Pharma Inc**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Star-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04081597
- **Lead sponsor:** Acanthas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-02
- **Primary completion:** 2020-03
- **Final completion:** 2020-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in Clinical Strategy
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04081597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04081597, "A Study of Single Ascending Doses of STAR-101 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04081597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*